The short version
11 companies supply this market — deep enough that no single failure threatens the supply.
Market view
paliperidone palmitate · Powder
30 marketed package NDCs · 11 active manufacturers
Most dispensed: 156 mg/mL · Injection · #1 syringe/kit / 1 ml in 1 syringe · 234 mg/1.5mL · Injection · #1 syringe/kit / 1.5 ml in 1 syringe · 1092 mg/3.5mL · Injection, Suspension, Extended Release · #1 syringe/carton / 3.5 ml in 1 syringe · 1560 mg/5mL · Injection, Suspension, Extended Release · #1 syringe/carton / 5 ml in 1 syringe
What changed in the last 90 days
Every detected change for paliperidone palmitate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- Invega TrinzaAug 19, 2026Price downNADAC $3996.05688 → $3995.10634 per unit (-0.02%)
- Invega TrinzaAug 19, 2026Price upNADAC $3986.32286 → $3993.20871 per unit (+0.17%)
- Invega TrinzaAug 19, 2026Price upNADAC $3948.15303 → $3959.97619 per unit (+0.3%)
- Invega TrinzaAug 19, 2026Price upNADAC $3935.44546 → $3950.94887 per unit (+0.39%)
- Invega SustennaAug 19, 2026Price downNADAC $2340.75042 → $2338.63319 per unit (-0.09%)
- Invega SustennaAug 19, 2026Price downNADAC $2339.48276 → $2337.63224 per unit (-0.08%)
- Invega SustennaAug 19, 2026Price downNADAC $2342.462 → $2340.7788 per unit (-0.07%)
- Invega SustennaAug 19, 2026Price upNADAC $2343.24941 → $2343.14947 per unit (0%)
- Invega SustennaAug 19, 2026Price upNADAC $2339.06997 → $2342.664 per unit (+0.15%)
- Invega TrinzaJul 22, 2026Price downNADAC $4001.52592 → $3996.05688 per unit (-0.14%)
Same drug class
Other molecules FDA puts in Atypical Antipsychotic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- olanzapine and fuoxetine· 1 maker
- olanzapine and samidorphan l-malate· 1 maker
- aripiprazole orally disintegrating· 2 makers
- lumateperone· 2 makers
- olanzapine and fluoxetine· 2 makers
- quetiapine fumarate er· 2 makers
- aripiprazole oral· 3 makers
- cariprazine· 3 makers
- lurasidone hcl· 3 makers
- asenapine· 4 makers
- aripiprazole lauroxil· 6 makers
- ziprasidone hcl· 6 makers
Common questions
- Is Paliperidone palmitate in shortage right now?
- No. FDA does not currently list Paliperidone palmitate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Paliperidone palmitate?
- 14 companies have marketed Paliperidone palmitate in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Paliperidone palmitate cost?
- The typical pharmacy pays about $2,343.15 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.